LIPOSOMES CONTAINING DOPAMINE ENTRAPPED IN RESPONSE TO TRANSMEMBRANE AMMONIUM SULFATE GRADIENT AS CARRIER SYSTEM FOR DOPAMINE DELIVERY INTO THE BRAIN OF PARKINSONIAN MICE

REFERENCES

• Handbook of Parkinson' Disease, W. C. Koller, G. Paulson. Marcel Dekker, , New York 1990
   Google Scholar
• Kucheryanu V. G., Yurasov V. V., Kryzhanovsky G. N., Nikushkin E. V., Zhigaltsev I. V., Kaplun A. P., Shvets V. I. The influence of free and liposomal L-DOPA on the development of parkinsonian syndrome in mice. Byulleten Eksperimentalnoi biologii i meditsini (Rus.). (Bulletin of Experimental Biology and Medicine (Engl.)) 1997; 123: 29–33
   Google Scholar
• Mori N., Sato T., Kumaschiro H. Anticonvulsant effect of systemically administered GABA-containing liposomes in rats induced to seizure by amygdaloid electrical stimulation. J. Lipid Res. 1992; 2: 49–55
   Google Scholar
• Naoi M., Yagi K. Incorporation of enzyme through blood-brain barrier into the brain by means of liposomes. Biochem. Int. 1980; 1: 591–596
   Google Scholar
• Sakamoto A., Ido T. Liposome targeting to the rat brain: effect of osmotic opening of blood-brain barrier. Brain Res. 1993; 629: 171–175
   PubMed Web of Science ®Google Scholar
• Osanai T., Nagai Y. Suppression of experimental allergic encephalomyelitis with liposome-encapsulated protease inhibitor: therapy through the blood-brain barrier. Neurochem. Res. 1984; 9: 1407–1416
   PubMed Web of Science ®Google Scholar
• Yagi K., Naoi M., Sasaci H., Abe H., Konishi H., Arichi S. Incorporation enzyme into the brain by means of liposomes of novel composition. J. Appl. Biochem. 1982; 4: 121–125
   Google Scholar
• Yurasov V. V., Kucheryanu V. G., Kaplun A. P., Zhigaltsev I. V., Nikushkin E. V., Shvets V. I., Kryzhanovsky G. N. Dopamine encapsulated in liposomes exerts antiparkinsonian effects in 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine-treated mice. Proc. of the 24th Int. Symp. on Controlled Release of Bioactive Materials, StockholmSweden 1997; 477–478
   Google Scholar
• Borisova N. V., Kaplun A. P., Bogomolov, Grigorev V. B., Yurasov V. V., Nikushkin E. V., Kryzhanovsky G. N., Shvets V. I. Physicochemical propertives of liposomal form of DOPA and dopamine. Bioorganicheskaya Khimiya (Rus.). (Russian Journal of Bioorganic Chemistry (Engl.)) 1996; 851–856, 2–294
   Google Scholar
• Nichols J. W., Deamer D. W. Catecholamine uptake and concentration by liposomes pH gradients. Biochim. Biophys. Acta. 1976; 455: 269–271
   PubMed Web of Science ®Google Scholar
• Mayer L. D., Bally M. B., Cullis P. R. Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim. Biophys. Acta. 1986; 857: 123–126
   PubMed Web of Science ®Google Scholar
• Madden T. D., Harrigan P. R., Tai L. C.L., Bally M. B., Mayer L. D., Redelmeier T. E., Loughrey H. C., Tilcock C. P.S., Reinish L. W., Cullis P. R. The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient. Chem. Phys. Lip. 1990; 53: 37–46
   PubMed Web of Science ®Google Scholar
• Mayer L. D., Tai L. C.L., Bally M. B., Mitilenes G. N., Ginsberg R. S., Cullis P. R. Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochim. Biophys. Acta. 1990; 1025: 143–151
   PubMed Web of Science ®Google Scholar
• Cullis P. R., Hope M. J., Bally M. B., Madden T. D., Mayer L. D., Fenske D. B. Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles. Biochim. Biophys. Acta. 1997; 1331: 187–211
   PubMed Web of Science ®Google Scholar
• Chakrabarti A. C., Clark-Lewis I., Harrigan P. R., Cullis P. R. Uptake of basic amino acids and peptides into liposomes in response to transmembrane pH gradients. Biophys. J. 1992; 61: 228–234
   PubMed Web of Science ®Google Scholar
• Chakrabarti A. C., Clark-Lewis I., Cullis P. R. Influence of charge, charge distribution, and hydrophobicity on the transport of short model peptides into liposomes in response to transmembrane pH gradients. Biochemistry 1994; 33: 8479–8485
   PubMed Web of Science ®Google Scholar
• Haran G., Cohen R., Bar L. K., Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produced efficient and stable entrapment of amphipatic weak bases. Biochim. Biophys. Acta. 1993; 1151: 201–215
   PubMed Web of Science ®Google Scholar
• Lasic D. D., Frederick P. M., Stuart M., Barenholz Y., McIntosh T. J. Gelation of liposome interior. A novel method for drug encapsulation. FEBS Letters 1992; 312: 255–258
   PubMed Web of Science ®Google Scholar
• Lasic D. D., Ceh B., Stuart M., Guo L., Frederick P. M., Barenholz Y. Transmembrane gradient driven phase transitions within vesicles: lesson for drug delivery. Biochim. Biophys. Acta. 1995; 1239: 145–156
   PubMed Web of Science ®Google Scholar
• Ceh B., Lasic D. D. A rigorous theory of remote loading of drugs into liposomes: transmembrane potential and induced pH-gradient loading and leakage of liposomes. J. Colloid Interface Sci. 1997; 185: 9–18
   PubMed Web of Science ®Google Scholar
• Borisova N. V., Zhigaltsev I. V., Kaplun A. P., Yurasov V. V., Bogomolov O. V., Kucheryanu V. G., Nikushkin E. V., Kryzhanovsky G. N., Shvets V. I. Liposomes from egg phosphatidylcholine with L-3,4-dihydxyphenylalanine (DOPA) and dopamine: lipid peroxidation, monoamine oxidation and the influence of components on the stability of each other. Bioorganicheskaya Khimiya (Rus.). (Russian Journal of Bioorganic Chemistry (Engl.)) 1997; 23: 289–294
   Google Scholar
• Heikkila R. E., Cabbat F. S., Mansino L., Duvoisin R. C. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on neostriatal dopamine in mice. Neuropharmacology 1984; 23: 711–713
   PubMed Web of Science ®Google Scholar
• Chiba K., Trevir A., Castagnoli N. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 1984; 120: 574–578
   PubMed Web of Science ®Google Scholar
• Kryzhanovsky G. N., Kucheryanu V. G., Pozdnyakov O. M., Kladkevich E. B., Krupina N. A., Nikushkin E. V., Oomura Y. Effects of fibroblast growth factors on MPTP-induced parkinsonian syndrome in mice. Pathophysiology 1997; 4: 59–67
   Google Scholar
• Yurasov V. V., Kucheryanu V. G., Podgorni G. N., Kudrin V. S., Kaplun A. P., Zhigaltsev I. V., Shvets V. I. Biochemical Effects of Conventional Liposomes in Mice Brain. Proc. of the 25th Int. Symp. on Controlled Release of Bioactive Materials, Las VegasUSA 1997; 394–395
   Google Scholar
• Chapat S., Frey V., Claperon N., Bouchaud C., Puisieux F., Couvreur P., Rossignol P., Delattre J. Efficiency of liposomal ATP in cerebral ischemia: bioavailability features. Brain. Res. Bull. 1991; 26: 339–342
   PubMed Web of Science ®Google Scholar
• Chen D., Li Q. T., Lee K. H. Antinociceptive activity of liposome-entrapped calcitonin by systemic administration in mice. Brain Res. 1993; 603: 139–142
   PubMed Web of Science ®Google Scholar
• Kreuter J., Alyautdin R. N., Kharkevich D. A., Ivanov A. A. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain. Res. 1995; 674: 171–174
   PubMed Web of Science ®Google Scholar
• Aliautdin R. N., Petrov V. E., Ivanov A. A., Kreuter J., Kharkevich D. A. Transport of the hexapeptide dalargin across the hemato-encephalic barrier into the brain using polymer nanoparticles. Eksp. Klin. Farmakol. 1996; 59: 57–60
   PubMedGoogle Scholar
• Nakamura M., Davila Zavala P., Tokuda H., Takakura Y., Hashida M. Uptake and gene expression of naked plasmid DNA in cultured brain microvessel endothelial cells. Biochem. Biophys. Res. Commun. 1998; 245: 235–239
   PubMed Web of Science ®Google Scholar
• Fenart L., Casanova A., Dehouck B., Duhem C., Slupek S., Cecchelli R., Betbeder D. Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the Blood-brain barrier. J Pharmacol. Exp. Ther. 1999; 291: 1017–1022
   PubMed Web of Science ®Google Scholar
• Gulyaev A. E., Gelperina S. E., Skidan I. N., Antropov A. S., Kivman G. Y., Kreuter J. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm. Res. 1999; 16: 1564–1569
   PubMed Web of Science ®Google Scholar